Integration of lipidomic and polygenic risk scores within contemporary clinical cardiovascular risk assessment pathways: a multi-cohort development and validation study
Aleksandar Dakic, Jing Qin Wu, Tingting Wang, Thomas G. Meikle et autres
Background: Guideline-recommended clinical risk scores such as AusCVDRisk underestimate cardiovascular disease (CVD) risk in a substantial proportion of individuals who later experience events, with up to 65% initially classified as low or intermediate risk. This limitation is most consequential in the intermediate-risk …
au, us, gb (code pays fourni par la source)
0 citations
EClinicalMedicine